Stockreport

UPDATE: Myovant stock rockets 79% premarket on news of positive trial of prostate cancer treatment [MarketWatch]

Myovant Sciences Ltd. Common Shares  (MYOV) 
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am Check Earnings Report
US:NYSE Investor Relations: investors.myovant.com
PDF UPDATE: Myovant stock rockets 79% premarket on news of positive trial of prostate cancer treatment Myovant Sciences Ltd. shares MYOV, +126.40% soared 79% in premarket [Read more]